Effects of the monoamine stabilizer (-)-OSU6162 on locomotor and sensorimotor responses predictive of antipsychotic activity. (Q53731838)

18 May 2018

http://europepmc.org/abstract/MED/29691608

title

Effects of the monoamine stabilizer (-)-OSU6162 on locomotor and sensorimotor responses predictive of antipsychotic activity. (English)

1 reference

18 May 2018

http://europepmc.org/abstract/MED/29691608

author

Elaine Del-Bel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29691608 AND SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Vívian T da Silveira

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29691608 AND SRC:MED&resulttype=core&format=json

11 June 2020

Jivago Röpke

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29691608 AND SRC:MED&resulttype=core&format=json

11 June 2020

Ana L Matosinhos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29691608 AND SRC:MED&resulttype=core&format=json

11 June 2020

Ana C Issy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29691608 AND SRC:MED&resulttype=core&format=json

11 June 2020

Antônio C de Oliveira

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29691608 AND SRC:MED&resulttype=core&format=json

11 June 2020

Fabrício A Moreira

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29691608 AND SRC:MED&resulttype=core&format=json

11 June 2020

publication date

24 April 2018

1 reference

18 May 2018

http://europepmc.org/abstract/MED/29691608

published in

Naunyn-Schmiedeberg's Archives of Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29691608 AND SRC:MED&resulttype=core&format=json

11 June 2020

volume

391

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29691608 AND SRC:MED&resulttype=core&format=json

11 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29691608 AND SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

761-768

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29691608 AND SRC:MED&resulttype=core&format=json

The catalepsy test: its ups and downs

11 June 2020

cites work

1 reference

12 December 2020

Catecholamines in the brain as mediators of amphetamine psychosis

1 reference

12 December 2020

Substituted (S)-phenylpiperidines and rigid congeners as preferential dopamine autoreceptor antagonists: synthesis and structure-activity relationships.

1 reference

12 December 2020

Long-lasting improvement following (-)-OSU6162 in a patient with Huntington's disease

1 reference

12 December 2020

PNU-96391A (OSU6162) antagonizes the development of behavioral sensitization induced by dopamine agonists in a rat model for Parkinson's disease

1 reference

12 December 2020

Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis

1 reference

12 December 2020

Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment

1 reference

12 December 2020

Schizophrenia: from dopamine to glutamate and back

1 reference

12 December 2020

How antipsychotics become anti-"psychotic"--from dopamine to salience to psychosis

1 reference

12 December 2020

Extrapyramidal symptoms with atypical antipsychotics : incidence, prevention and management

1 reference

12 December 2020

Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice

1 reference

12 December 2020

The dopaminergic stabilizers (-)-OSU6162 and ACR16 reverse ( )-MK-801-induced social withdrawal in rats

1 reference

12 December 2020

Modern antipsychotic drugs: a critical overview

1 reference

12 December 2020

The place of partial agonism in psychiatry: recent developments

1 reference

12 December 2020

From dopamine to salience to psychosis--linking biology, pharmacology and phenomenology of psychosis.

1 reference

12 December 2020

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

12 December 2020

Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade

1 reference

12 December 2020

The dopamine stabilizers (S)-(-)-(3-methanesulfonyl-phenyl)-1-propyl-piperidine [(-)-OSU6162] and 4-(3-methanesulfonylphenyl)-1-propyl-piperidine (ACR16) show high in vivo D2 receptor occupancy, antipsychotic-like efficacy, and low potential for mot

1 reference

12 December 2020

Assays for enhanced activity of low efficacy partial agonists at the D(2) dopamine receptor

1 reference

12 December 2020

Dopamine partial agonist action of (-)OSU6162 is consistent with dopamine hyperactivity in psychosis

1 reference

12 December 2020

The atypical antipsychotic, aripiprazole, blocks phencyclidine-induced disruption of prepulse inhibition in mice

1 reference

12 December 2020

Dopamine: 50 years in perspective

1 reference

12 December 2020

Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice

1 reference

12 December 2020

Effects of aripiprazole/OPC-14597 on motor activity, pharmacological models of psychosis, and brain activity in rats.

1 reference

12 December 2020

Effects of (-)-OSU6162 and ACR16 on motor activity in rats, indicating a unique mechanism of dopaminergic stabilization

1 reference

12 December 2020

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

1 reference

12 December 2020

Nitric oxide modulation of methylphenidate-induced disruption of prepulse inhibition in Swiss mice

1 reference

12 December 2020

1 reference

12 December 2020

Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?

1 reference

12 December 2020

Effects of aripiprazole on MK-801-induced prepulse inhibition deficits and mitogen-activated protein kinase signal transduction pathway.

1 reference

12 December 2020

Analysis of the actions of the novel dopamine receptor-directed compounds (S)-OSU6162 and ACR16 at the D2 dopamine receptor

1 reference

12 December 2020

II. In vitro evidence that (-)-OSU6162 and ( )-OSU6162 produce their behavioral effects through 5-HT2A serotonin and D2 dopamine receptors

1 reference

12 December 2020

I. In vivo evidence for partial agonist effects of (−)-OSU6162 and ( )-OSU6162 on 5-HT2A serotonin receptors

1 reference

12 December 2020

From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment

1 reference

12 December 2020

Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head-head comparisons

1 reference

12 December 2020

The dopamine stabilizers ACR16 and (−)-OSU6162 display nanomolar affinities at the σ-1 receptor

1 reference

12 December 2020

Antipsychotics in Adults With Schizophrenia: Comparative Effectiveness of First-Generation Versus Second-Generation Medications

1 reference

12 December 2020

Effects of aripiprazole, an atypical antipsychotic, on the motor alterations induced by acute ethanol administration in mice

1 reference

12 December 2020

Translational value of startle modulations

1 reference

12 December 2020

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

1 reference

12 December 2020

Animal models for predicting the efficacy and side effects of antipsychotic drugs

1 reference

12 December 2020

Schizophrenia: from dopaminergic to glutamatergic interventions

1 reference

12 December 2020

Tolerability and efficacy of the monoaminergic stabilizer (-)-OSU6162 (PNU-96391A) in Huntington's disease: a double-blind cross-over study

1 reference

12 December 2020

Glutamate and dopamine in schizophrenia: an update for the 21st century

1 reference

12 December 2020

Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders

1 reference

12 December 2020

The effects of the monoamine stabilizer (-)-OSU6162 on craving in alcohol dependent individuals: A human laboratory study

1 reference

12 December 2020

The effects of the dopamine stabilizer (-)-OSU6162 on aggressive and sexual behavior in rodents

1 reference

12 December 2020

Sensorimotor gating of the startle reflex: what we said 25 years ago, what has happened since then, and what comes next

1 reference

12 December 2020

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

1 reference

12 December 2020

Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors.

1 reference

12 December 2020

10.1007/S00210-018-1500-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29691608 AND SRC:MED&resulttype=core&format=json

release_z23m7rfa65fmljyyigvzpgduyq

11 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/z23m7rfa65fmljyyigvzpgduyq

24 November 2022

mapped directly with Wikidata item

1 reference